Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Immutep Announces New Biomarker Data From The TACTI-002/KEYNOTE-798 Phase 2 Trial Of Eftilagimod Alpha Combined With Merck's Keytruda As First-line Treatment For Unresectable Or Metastatic Non-small Cell Lung Cancer - 8K

Author: Benzinga Newsdesk | November 03, 2023 06:11am

Posted In: IMMP